Insulet (PODD) Misses Q4 EPS by 22c, Guidance Comes in Light
Get Alerts PODD Hot Sheet
Price: $146.87 -2.46%
Revenue Growth %: +18.1%
Financial Fact:
Total operating expenses: 53.22M
Today's EPS Names:
PMCB, CULP, HURC, More
Revenue Growth %: +18.1%
Financial Fact:
Total operating expenses: 53.22M
Today's EPS Names:
PMCB, CULP, HURC, More
Join SI Premium – FREE
Insulet (NASDAQ: PODD) reported Q4 EPS of ($0.48), $0.22 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $100.1 million versus the consensus estimate of $91.89 million.
GUIDANCE:
Insulet sees Q1 2016 revenue of $77-80 million, versus the consensus of $83.19 million.
Insulet sees FY2016 revenue of $330-350 million, versus the consensus of $360.08 million.
For earnings history and earnings-related data on Insulet (PODD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Asana, Inc. (ASAN) Tops Q2 EPS by 1c; offers guidance
- BlackRock’s Rosenberg says inflation data key after jobs beat
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share